Creo Medical Group PLC (CMEOF)

Market Cap	63.65M +12.8%
Revenue (ttm)	9.29M +62.8%
Net Income	-26.67M
EPS	-0.07
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	3,000
Open	0.1500
Previous Close	0.2256
Day's Range	0.1500 - 0.1500
52-Week Range	0.1500 - 0.2256
Beta	0.95
Analysts	n/a
Price Target	n/a
Est. Earnings	Dec 23, 2026

About Creo Medical Group

Creo Medical Group PLC, through its subsidiaries, engages in the research, development, manufacture, and sale of medical devices and instruments for clinics and hospitals in the United Kingdom. It develops CROMA, an energy platform that combines bipolar radiofrequency for precise localized cutting and microwave energy for controlled coagulation, to provide physicians with controllable devices delivered through an endoscope. It also offers Speedboat Inject, an energy multimodal instrument for endoscopy; MicroBlate Fine, a microwave needle ablati...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2003
• Employees: 104
• Stock Exchange: OTCMKTS
• Ticker Symbol: CMEOF

Financial Performance

Financial numbers in GBP

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Nov 9, 2026

Data Sources Report a data error